Associations Between Comorbidity, and Overall Survival and Bladder Cancer Specific Survival After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 85-93

  Fairey, Adrian S ^a,c   Jacobsen, Niels Erik B ^a,c   Chetner, Michael P ^a,c   Mador, David R ^a   Metcalfe, James B ^a   Moore, Ronald B ^a,b   Rourke, Keith F ^a,c   Todd, Gerald T ^a,c   Venner, Peter M ^b   Voaklander, Don C ^a   Estey, Eric P ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Alberta Urology Institute   (Canada)

Author keywords

cystectomy; mortality; survival; urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANADA; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; TUMOR VOLUME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBERTA; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CYSTECTOMY; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SOCIETIES, MEDICAL; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 67349181945     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.111     Document Type: Article

References (20)

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (Including Upper Tract Tumors and Urothelial Carcinoma of the Prostate) V. 2.2008. www.nccn.org Accessed June 1, 2008
2. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
3. Madersbacher S., Hochreiter W., Burkhard F., Thalmann G.N., Danuser H., Markwalder R., et al. Radical cystectomy for bladder cancer today-a homogenous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690
4. Shariat S.F., Karakiewicz P.I., Palapattu G.S., Lotan Y., Rogers C.G., Amiel G.E., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414
5. Herr H.W., Bochner B.H., Dalbagni S., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295
6. Lotan Y., Gupta A., Shariat S.F., Palapattu G.S., Vazina A., Karakiewicz P.I., et al. Lymphvascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533
7. Koppie T.M., Vickers A.J., Vora K., Dalbagni G., and Bochner B.H. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?. Cancer 107 (2006) 2368
8. Koppie T.M., Serio A.M., Vickers A.J., Vora K., Dalbagni G., Donat S.M., et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112 (2008) 2384
9. Lee C.T., Dunn R.L., Chen B.T., Joshi D.P., Sheffield J., Montie J.E., et al. Impact of body mass index on radical cystectomy. J Urol 172 (2004) 1281
10. Megwalu I.I., Vlahiotis A., Radwan M., Piccirillo J.F., and Kibel A.S. Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol 53 (2008) 581
11. Fairey A., Chetner M., Metcalfe J., Moore R., Todd G., Rourke K., et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol 180 (2008) 128
12. Herr H., Lee C., Chang S., and Lerner S. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171 (2004) 1823
13. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004) 2441
14. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., and Wei J.T. The impact of co-morbid disease on cancer control and overall survival following radical cystectomy. J Urol 169 (2003) 105
15. Koch M.O., and Smith J.A. Influence of patient age and co-morbidity on outcome of a collaborative care pathway after radical prostatectomy and cystoprostatectomy. J Urol 155 (1996) 1681
16. Chang S.S., Alberts G., Cookson M.S., and Smith J.A. Radical cystectomy is safe is elderly patients at high risk. J Urol 166 (2001) 938
17. Konety B.R., Dhawan V., Allareddy V., and Joslyn S. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 173 (2005) 1695
18. Birkmeyer J.D., Stukel T.A., Siewers A.E., Goodney P.P., Wennberg D.E., and Lucas L. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117
19. Vickers A.J., Bianco F.J., Serio A.M., Eastham J.A., Schrag D., Klein E., et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 99 (2007) 1171
20. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy for invasive bladder cancer (individual patient data). Cochrane Database Syst Rev 2 (2006) CD006018